Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Fuchs

Showing results (71-80 of 257) with videos related to

Pageof 26
Sort By:
The Journal of Antimicrobial Chemotherapy|June 1, 1994
Antibacterial activity of PD 131628 and proposed disc diffusion susceptibility test criteriaP C Fuchs, A L Barry, M A Pfaller
Diagnostic Microbiology and Infectious Disease|February 17, 1999
In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk testP C Fuchs, A L Barry, S D Brown
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1991
Susceptibility of Haemophilus influenzae to clarithromycin alone and in combination with its 14-hydroxy metaboliteA L Barry, P C Fuchs, M A Pfaller
Antimicrobial Agents and Chemotherapy|August 4, 1998
In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzaeA L Barry, P C Fuchs, S D Brown
Diagnostic Microbiology and Infectious Disease|September 1, 1987
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteriaP C Fuchs, R N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease|September 1, 1989
Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing GroupA L Barry, P C Fuchs, R N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1997
Susceptibility testing quality control studies with fosfomycin tromethamineP C Fuchs, A L Barry, S D Brown
Journal of Clinical Microbiology|February 18, 1998
Quality control limits for dilution and disk diffusion susceptibility tests of trovafloxacin against eight quality control strainsP C Fuchs, A L Barry, S D Brown
Journal of Chemotherapy (Florence, Italy)|March 10, 1998
Streptococcus pneumoniae killing rate and post-antibiotic effect of levofloxacin and ciprofloxacinP C Fuchs, A L Barry, S D Brown
Antimicrobial Agents and Chemotherapy|September 19, 2000
Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicatorP C Fuchs, A L Barry, S D Brown
Pageof 26

Showing results (71-80 of 257) with videos related to

Sort By:
Pageof 26
The Journal of Antimicrobial Chemotherapy|June 1, 1994
Antibacterial activity of PD 131628 and proposed disc diffusion susceptibility test criteriaP C Fuchs, A L Barry, M A Pfaller
Diagnostic Microbiology and Infectious Disease|February 17, 1999
In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk testP C Fuchs, A L Barry, S D Brown
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1991
Susceptibility of Haemophilus influenzae to clarithromycin alone and in combination with its 14-hydroxy metaboliteA L Barry, P C Fuchs, M A Pfaller
Antimicrobial Agents and Chemotherapy|August 4, 1998
In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzaeA L Barry, P C Fuchs, S D Brown
Diagnostic Microbiology and Infectious Disease|September 1, 1987
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteriaP C Fuchs, R N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease|September 1, 1989
Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing GroupA L Barry, P C Fuchs, R N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1997
Susceptibility testing quality control studies with fosfomycin tromethamineP C Fuchs, A L Barry, S D Brown
Journal of Clinical Microbiology|February 18, 1998
Quality control limits for dilution and disk diffusion susceptibility tests of trovafloxacin against eight quality control strainsP C Fuchs, A L Barry, S D Brown
Journal of Chemotherapy (Florence, Italy)|March 10, 1998
Streptococcus pneumoniae killing rate and post-antibiotic effect of levofloxacin and ciprofloxacinP C Fuchs, A L Barry, S D Brown
Antimicrobial Agents and Chemotherapy|September 19, 2000
Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicatorP C Fuchs, A L Barry, S D Brown
Pageof 26